Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Jun;24(3):401–406.

Measles infection. Involvement of the complement system.

J A Charlesworth, B A Pussell, L P Roy, M R Robertson, J Beveridge
PMCID: PMC1538541  PMID: 939047

Abstract

The complement system was examined in fifty patients with acute, apparently uncomplicated measles; forty-six were children less than 10 years old. Twenty showed evidence of pathological complement activation. In thirteen of these the pattern was consistent with activation of the classical pathway while in the other seven data suggested utilization of an alternative pathway. An additional eleven patients had isolated reduction in Clq without alteration in concentration of other components; these were excluded from the classical pathway group. No patient had detectable immune complexes or C3 splitting activity in serum; however, it is suggested that the abnormal complement patterns observed are likely to indicate the presence of circulating immune complexes in a high percentage of patients with this infection.

Full text

PDF
401

Images in this article

403FIG. 2
on p.403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS J. M., IMAGAWA D. T. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med. 1962 Dec;111:562–566. doi: 10.3181/00379727-111-27855. [DOI] [PubMed] [Google Scholar]
  2. Agnello V., Winchester R. J., Kunkel H. G. Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. Immunology. 1970 Dec;19(6):909–919. [PMC free article] [PubMed] [Google Scholar]
  3. Alper C. A., Rosen F. S. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967 Dec;46(12):2021–2034. doi: 10.1172/JCI105691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brody J. A., Sever J. L., Edgar A., McNew J. Measles antibody titers of multiple sclerosis patients and their siblings. Neurology. 1972 May;22(5):492–499. doi: 10.1212/wnl.22.5.492. [DOI] [PubMed] [Google Scholar]
  5. Brown P., Cathala F., Gajdusek D. C., Gibbs C. J., Jr Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis. Proc Soc Exp Biol Med. 1971 Jul;137(3):956–961. doi: 10.3181/00379727-137-35704. [DOI] [PubMed] [Google Scholar]
  6. Charlesworth J. A., Williams D. G., Sherington E., Lachmann P. J., Peters D. K. Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest. 1974 Jun;53(6):1578–1587. doi: 10.1172/JCI107708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Connolly J. H., Allen I. V., Hurwitz L. J., Millar J. H. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet. 1967 Mar 11;1(7489):542–544. doi: 10.1016/s0140-6736(67)92117-4. [DOI] [PubMed] [Google Scholar]
  8. Dayan A. D., Gostling J. V., Greaves J. L., Stevens D. W., Woodhouse M. A. Evidence of a pseudomyxovirus in the brain in subacute sclerosing leucoencephalitis. Lancet. 1967 May 6;1(7497):980–981. doi: 10.1016/s0140-6736(67)92360-4. [DOI] [PubMed] [Google Scholar]
  9. Dayan A. D., Stokes M. I. Immune complexes and visceral deposits of measles antigens in subacute sclerosing panencephalitis. Br Med J. 1972 May 13;2(5810):374–376. doi: 10.1136/bmj.2.5810.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ecker E. E., Seifter S., Dozois T. F., Barr L. COMPLEMENT IN INFECTIOUS DISEASE IN MAN. J Clin Invest. 1946 Nov;25(6):800–808. doi: 10.1172/JCI101766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ensky J., Hinz C. F., Jr, Todd E. W., Wedgwood R. J., Boyer J. T., Lepow I. H. Properties of highly purified human properdin. J Immunol. 1968 Jan;100(1):142–158. [PubMed] [Google Scholar]
  12. Jersild C., Fog T., Hansen G. S., Thomsen M., Svejgaard A., Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet. 1973 Dec 1;2(7840):1221–1225. doi: 10.1016/s0140-6736(73)90970-7. [DOI] [PubMed] [Google Scholar]
  13. Johnson K. P., Byington D. P. Subacute sclerosing panencephalitis (SSPE) agent in hamsters. I. Acute giant cell encephalitis in newborn animals. Exp Mol Pathol. 1971 Dec;15(3):373–379. doi: 10.1016/0014-4800(71)90044-x. [DOI] [PubMed] [Google Scholar]
  14. Joseph B. S., Cooper N. R., Oldstone M. B. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway. J Exp Med. 1975 Apr 1;141(4):761–774. [PMC free article] [PubMed] [Google Scholar]
  15. Katz M., Oyanagi S., Koprowski H. Subacute sclerosing panencephalitis: structures resembling myxovirus nucleocapsids in cells cultured from brain. Nature. 1969 May 31;222(5196):888–890. doi: 10.1038/222888a0. [DOI] [PubMed] [Google Scholar]
  16. Kohler P. F., Müller-Eberhard H. J. Complement-immunoglobulin relation: deficiency of C'1q associated with impaired immunoglobulin G synthesis. Science. 1969 Jan 31;163(3866):474–475. doi: 10.1126/science.163.3866.474. [DOI] [PubMed] [Google Scholar]
  17. Kohler P. F., Müller-Eberhard H. J. Metabolism of human C1q. Studies in hypogammaglobulinemia, myeloma, and systemic lupus erythematosus. J Clin Invest. 1972 Apr;51(4):868–875. doi: 10.1172/JCI106881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  19. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  20. Peters D. K., Charlesworth J. A., Sissons J. G., Williams D. G., Boulton-Jones J. M., Evans D. J., Kourilsky O., Morel-Maroger L. Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet. 1973 Sep 8;2(7828):535–538. doi: 10.1016/s0140-6736(73)92351-9. [DOI] [PubMed] [Google Scholar]
  21. Peters D. K., Martin A., Weinstein A., Cameron J. S., Barratt T. M., Ogg C. S., Lachmann P. J. Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol. 1972 Jul;11(3):311–320. [PMC free article] [PubMed] [Google Scholar]
  22. Pollard P. A., Shafar J., Knowlson P. A., Tallett E. R. Clonidine in migraine. Lancet. 1972 Jun 3;1(7762):1242–1243. doi: 10.1016/s0140-6736(72)90965-8. [DOI] [PubMed] [Google Scholar]
  23. Salmi A., Gollmar Y., Norrby E., Panelius M. Antibodies against three different structural components of measles virus in patients with multiple sclerosis, their siblings and matched controls. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Oct;81(5):627–634. doi: 10.1111/j.1699-0463.1973.tb02253.x. [DOI] [PubMed] [Google Scholar]
  24. Sell K. W., Thurman G. B., Ahmed A., Strong D. M. Plasma and spinal-fluid blocking factor in SSPE. N Engl J Med. 1973 Jan 25;288(4):215–216. doi: 10.1056/nejm197301252880418. [DOI] [PubMed] [Google Scholar]
  25. Thormar H., Jervis G. A., Karl S. C., Brown H. R. Passage in ferrets of encephalitogenic cell-associated measles virus isolated from brain of a patient with subacute sclerosing panencephalitis. J Infect Dis. 1973 Jun;127(6):678–685. doi: 10.1093/infdis/127.6.678. [DOI] [PubMed] [Google Scholar]
  26. Vallota E. H., Forristal J., Davis N. C., West C. D. The C3 nephritic factor and membranoproliferative nephritis: correlation of serum levels of the nephritic factor with C3 levels, with therapy, and with progression of the disease. J Pediatr. 1972 Jun;80(6):947–959. doi: 10.1016/s0022-3476(72)80006-4. [DOI] [PubMed] [Google Scholar]
  27. Vandvik B., Norrby E. Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A. 1973 Apr;70(4):1060–1063. doi: 10.1073/pnas.70.4.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Williams D. G., Peters D. K., Fallows J., Petrie A., Kourilsky O., Morel-Maroger L., Cameron J. S. Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol. 1974 Nov;18(3):391–405. [PMC free article] [PubMed] [Google Scholar]
  29. Williams D. G., Scopes J. W., Peters D. K. Hypocomplementaemic membranoproliferative glomerulonephritis and nephrotic syndrome associated with partial lipodystrophy of the face and trunk. Proc R Soc Med. 1972 Jul;65(7):591–591. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES